Supramolecular encapsulation of pulegone from oriental herb, Schizonepeta tenuifolia Briquet by β;- and γ;-cyclodextrins

Bulletin of the Korean Chemical Society

Volumn 29, Issue 8, 2008, Pages 1579-1582

  Moon, Tae Won ^a   Ji, Won Lee ^a   Jhee, Kwang Hwan ^a   Khang, Kong Won ^b   Jeong, Ho Soon ^b   Yang, Seun Ah ^c   Kim, Hee Joon ^a  

^a Kumoh National Institute of Technology   (South Korea)

^b Chephilos Corp   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

Cyclodextrins; Encapsulation; Phytochemicals; Pulegone; Supramolecules

Indexed keywords

EID: 50449096101     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2008.29.8.1579     Document Type: Article

References (29)

1. (a) Grundschober, F. Perfumer 1979, 415-417.
2. (b) Sullivan, J. B.; Rumack, B. H.; Thomas, H.; Peterson, R. G.; Brysch, P. J. Am. Med. Assoc. 1979, 242, 2873-2874.
3. Li, Z. Q.; Li, Q. C.; Luo, L.; Li, C.; Huang, R.; Gao, T. R. Acta Botanica Yunnanica. 1996, 18, 115-122.
4. (a) Hall, R. L.; Oser, B. L. Food Technology 1965, 19, 253-271.
5. (b) de Sousa, D. P.; Junior, E. V.; Oliveria, F. S.; de Almeida, R. N.; Nunes, X. P.; Barbosa-Filho, J. M. Z. Naturforsch C 2007, 62, 39-42.
6. (c) Park, I. K.; Kim, L. S.; Choi, I. H.; Lee, Y. S.; Shin, S. C. J. Econ. Entomol. 2006, 99, 1717-1721.
7. (a) http://www.cfsan.fda.gov./~lrd/fcf182.html. FDA, Rockville, MD (Accessed Nov 30, 2006).
8. (b) Williams, A. C.; Barry, B. W. Pharm. Res. 1991, 8, 17-24.
9. (a) Kang, L.; Yap, C. W.; Lim, P. F.; Chen, Y. Z.; Ho, P. C.; Chan, Y. W.; Wong, G. P.; Chan, S. Y. J. Control Release 2007, 120, 211-219.
10. (b) Narishetty, S. T.; Panchagnula, R. J. Control Release 2004, 95, 367-379.
11. Budarari, S. The Merck Index, 13th ed.; Whitehouse Station: New Jersey, 2001; p 8028.
12. (a) Szetjli, J. Chem. Rev. 1998, 98, 1743-1753.
13. (b) Comprehensive Supramolecular Chemistry; Volume Editors: Szejtli, J., Osa, T.; Series Editors: Atwood, J. L., Davies, J. E., MacNicol, D. D., Vogtle, F.; Pergamon/Elsevier: Oxford, 1996; Vol. 3.
14. Szetjli, J. TIBTRCH 1989, 7, 171-174.
15. (a) Horvath, G.; Premkumar, T.; Boztas, A.; Lee, E.; Jon, S.; Geckeler, K. E. Molecular Pharmaceutics 2008, 5, 358-363.
16. (b) Muñoz-Botella, S.; del Castillo, B.; Martÿn, M. A. Ars. Pharm. 1995, 36, 187-198.
17. (c) Loftsson, T.; Brewster, M. E. J. Pharm. Sci. 1996, 85, 1017-1025.
18. (d) Kim, H.; Kim, H.-W.; Jung, S. Bull. Korean Chem. Soc. 2008, 29, 590-594.
19. (a) Del Valle, E. M. M. Process Biochemistry 2004, 39, 1033-1046.
20. (b) Hedges, R. A. Chem. Rev. 1998, 98, 2035.
21. (c) Szejtli, J. Cyclodextrin Technology; Kluwer: Dordrecht, 1988.
22. (a) Nash, R. A. Handbook of Pharmaceutical Excipients; Wade, A., Weller, P. J., Eds.; Press & Am. Pharm. Assoc.: London, 1994; pp 145-148.
23. (b) Irie, T.; Uekama, K. J. Pharm. Sci. 1997, 86, 147-162.
24. (c) Thompson, D. O. Crit. Rev. Ther. Drug Carrier Syst. 1997, 14, 1-104.
25. The results from molecular dynamics simulations of pulegone binding to permethylated β-cyclodextrins have been reported: Lipkowitz, K. B.; Coner, R.; Peterson, M. A.; Morreale, A.; Shackelford, J. J. Org. Chem. 1998, 63, 732-745.
26. Cho, H.-J.; Yoo, D.-C.; Kim, H.-J.; Khang, K.-W.; Jeong, H.-S.; Yang, S.-A.; Lee, I.-S.; Jhee, K.-H. submitted for publication.
27. Rusa, C. C.; Luca, C.; Tonelli, A. E. Macromolecules 2001, 34, 1318-1322.
28. Giordano, F.; Novak, C.; Moyano, J. R. Thermochim. Acta 2001, 380, 123-151.
29. In the TGA diagrams for 1 and 2, the residual amounts after thermal decomposition are attributed to the decomposed carbon-based species such as soot or tar.